Literature DB >> 2833748

Heart and bone tumors in transgenic mice.

R R Behringer1, J J Peschon, A Messing, C L Gartside, S D Hauschka, R D Palmiter, R L Brinster.   

Abstract

Tissue-specific tumorigenesis can be induced in transgenic mice by the directed expression of simian virus 40 (SV40) large tumor (T) antigen. In an attempt to determine the susceptibility of haploid, round spermatids to neoplastic transformation by this oncogene, transgenic mice were generated that harbored a chimeric gene composed of the SV40 T-antigen genes fused to the 5' and 3' flanking sequences of the mouse protamine 1 gene. The transgene was expressed in round spermatids and, surprisingly, in the heart and temporal bone as well. Expression in the heart resulted in rhabdomyosarcomas that always appeared in the right atrium. Bilateral osteosarcomas developed within the petrous portion of the temporal bone. No testicular pathology was observed. T-antigen immunostaining was readily detected in tumor tissue but not in the testis. In addition, SV40 transcripts were processed differently in testis and tumor tissue. Transgenic mouse lines were established that routinely develop these tumors, and they should provide a valuable resource for studies involving cardiac and bone physiology and neoplasia. The atrial tumor cells can be maintained in vitro and some continue to display a cardiac muscle phenotype.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833748      PMCID: PMC280055          DOI: 10.1073/pnas.85.8.2648

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

2.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

3.  A method for isolation of intact, translationally active ribonucleic acid.

Authors:  G Cathala; J F Savouret; B Mendez; B L West; M Karin; J A Martial; J D Baxter
Journal:  DNA       Date:  1983

Review 4.  Cardiac muscle cell proliferation and cell differentiation in vivo and in vitro.

Authors:  W C Claycomb
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

5.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

6.  Translational regulation and deadenylation of a protamine mRNA during spermiogenesis in the mouse.

Authors:  K C Kleene; R J Distel; N B Hecht
Journal:  Dev Biol       Date:  1984-09       Impact factor: 3.582

7.  Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium.

Authors:  T A Linkhart; C H Clegg; S D Hauschika
Journal:  Dev Biol       Date:  1981-08       Impact factor: 3.582

8.  Haploid accumulation and translational control of phosphoglycerate kinase-2 messenger RNA during mouse spermatogenesis.

Authors:  B Gold; H Fujimoto; J M Kramer; R P Erickson; N B Hecht
Journal:  Dev Biol       Date:  1983-08       Impact factor: 3.582

9.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.

Authors:  D Bader; T Masaki; D A Fischman
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

View more
  28 in total

1.  The MRE11-NBS1-RAD50 pathway is perturbed in SV40 large T antigen-immortalized AT-1, AT-2 and HL-1 cardiomyocytes.

Authors:  N A Lanson; D B Egeland; B A Royals; W C Claycomb
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

2.  A Functional chromatin domain does not resist X chromosome inactivation: silencing of cLys correlates with methylation of a dual promoter-replication origin.

Authors:  Suyinn Chong; Joanna Kontaraki; Constanze Bonifer; Arthur D Riggs
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 3.  Cell cycle regulation to repair the infarcted myocardium.

Authors:  Joshua D Dowell; Loren J Field; Kishore B S Pasumarthi
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

4.  A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression.

Authors:  S Navankasattusas; H Zhu; A V Garcia; S M Evans; K R Chien
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

Review 5.  Cell-based approaches for cardiac repair.

Authors:  Michael Rubart; Loren J Field
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

6.  Myocardial regeneration. Transplanting satellite cells into damaged myocardium.

Authors:  P D Yoon; R L Kao; G J Magovern
Journal:  Tex Heart Inst J       Date:  1995

7.  Comparative methylation analysis of murine transgenes that undergo or escape X-chromosome inactivation.

Authors:  M A Goldman; P S Reeves; C M Wirth; W J Zupko; M A Wong; S Edelhoff; C M Disteche
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

8.  Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.

Authors:  S P Yee; D Mock; P Greer; V Maltby; J Rossant; A Bernstein; T Pawson
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

9.  Cardiac and skeletal myopathy in beta myosin heavy-chain simian virus 40 tsA58 transgenic mice.

Authors:  J R De Leon; H J Federoff; D W Dickson; K L Vikstrom; G I Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.

Authors:  T Teitz; J C Chang; M Kitamura; T S Yen; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.